Queen’s University Belfast Declares 100th Spin-Out Company – AilseVax
AilseVax will identify and develop novel therapeutic vaccines for cancer patients, which work with the body’s immune system to overcome cancer. These cancer vaccines are a form of immunotherapy that can help educate the immune system about what cancer cells “look like” so that it can recognise and destroy them using the body’s own defences. […]